Profile
Charbel Haber is currently working as the Senior Vice President-Regulatory Science at Moderna, Inc. Prior to this, he worked as the VP-Global Safety & Regulatory Sciences at Biogen, Inc. from 2017 to 2020.
He also held the position of Head-Regulatory Affairs Immunology & Neurology at EMD Serono, Inc.
Charbel Haber active positions
| Companies | Position | Start |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 21/04/2020 |
Former positions of Charbel Haber
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2020 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
- Stock Market
- Insiders
- Charbel Haber
















